108 lines
No EOL
32 KiB
XML
108 lines
No EOL
32 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-toc" /><meta name="ncbi_acc" content="NBK83459" /><meta name="ncbi_domain" content="nicecg113" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK83459/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Generalised Anxiety Disorder in Adults - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="NOINDEX,NOFOLLOW,NOARCHIVE,NOIMAGEINDEX" /><meta name="author" content="National Collaborating Centre for Mental Health (UK)" /><meta name="citation_title" content="Generalised Anxiety Disorder in Adults" /><meta name="citation_publisher" content="British Psychological Society" /><meta name="citation_date" content="2011" /><meta name="citation_author" content="National Collaborating Centre for Mental Health (UK)" /><meta name="citation_pmid" content="22536620" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK83459/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Generalised Anxiety Disorder in Adults" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="British Psychological Society" /><meta name="DC.Contributor" content="National Collaborating Centre for Mental Health (UK)" /><meta name="DC.Date" content="2011" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK83459/" /><meta name="description" content="This clinical guideline is an update of NICE’s previous guidance on generalised anxiety disorder. It was commissioned by NICE and developed by the National Collaborating Centre for Mental Health, and sets out clear evidence- and consensus-based recommendations for healthcare professionals on how to treat and manage generalised anxiety disorder in adults." /><meta name="og:title" content="Generalised Anxiety Disorder in Adults" /><meta name="og:type" content="book" /><meta name="og:description" content="This clinical guideline is an update of NICE’s previous guidance on generalised anxiety disorder. It was commissioned by NICE and developed by the National Collaborating Centre for Mental Health, and sets out clear evidence- and consensus-based recommendations for healthcare professionals on how to treat and manage generalised anxiety disorder in adults." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK83459/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nicecg113-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="warning" content="July 2019: Because of a risk of abuse and dependence, pregabalin is controlled under the Misuse of Drugs Act 1971 as a class C substance and scheduled under the Misuse of Drugs Regulations 2001 as schedule 3 (as of 1 April 2019). A footnote has been added by NICE to this guideline to reflect this change. Minor updates since publication July 2019: Recommendation 1.4.39 was amended to remove structured problem solving as a care and management option as this had originally been included in error. June 2018: Recommendation 1.2.13 was amended with advice on CBT. Recommendation 1.2.26 was updated with a link to the newest evidence on use of antipsychotics for treatment of GAD. Recommendation 1.4.7 was added to link to existing guidance on identifying treatment options for common mental health problems. Recommendation 1.4.10 on low-intensity interventions for mild to moderate panic disorder and 1.4.13 on treatment for moderate to severe panic disorder were added from the NICE guideline on common mental health disorders. Section 1.4 on stepped care for people with panic disorder was reordered." /><meta name="bk-non-canon-loc" content="/books/n/nicecg113/toc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK83459/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8E98537D7913110000000000CD0094.m_5" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-toc">
|
||
<div class="grid no_max_width">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
|
||
<div class="header">
|
||
|
||
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<div class="container content">
|
||
<div class="source">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p></div><div class="bk_msg_box bk_bttm_mrgn clearfix bk_noprnt"><div class="iconblock clearfix"><a class="img_link icnblk_img" title="Table of Contents Page" href="/books/n/nicecg113guid/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nicecg113guid-lrg.png" alt="Cover" height="100px" width="80px" /></a><div class="icnblk_cntnt"><ul class="messages"><li class="info icon"><span class="icon"><a href="/books/n/nicecg113guid/">See 2019 Partial Update</a></span></li></ul></div></div></div><div class="messagearea bk_noprnt" style="margin-bottom:1.3846em "><ul class="messages"><li class="warn icon"><span class="icon">July 2019: Because of a risk of abuse and dependence, pregabalin is controlled under the Misuse of Drugs Act 1971 as a class C substance and scheduled under the Misuse of Drugs Regulations 2001 as schedule 3 (as of 1 April 2019). A footnote has been added by NICE to this guideline to reflect this change. Minor updates since publication July 2019: Recommendation 1.4.39 was amended to remove structured problem solving as a care and management option as this had originally been included in error. June 2018: Recommendation 1.2.13 was amended with advice on CBT. Recommendation 1.2.26 was updated with a link to the newest evidence on use of antipsychotics for treatment of GAD. Recommendation 1.4.7 was added to link to existing guidance on identifying treatment options for common mental health problems. Recommendation 1.4.10 on low-intensity interventions for mild to moderate panic disorder and 1.4.13 on treatment for moderate to severe panic disorder were added from the NICE guideline on common mental health disorders. Section 1.4 on stepped care for people with panic disorder was reordered.</span></li></ul></div><div class="bk_prnt"><p style="color:red;"><strong>July 2019: Because of a risk of abuse and dependence, pregabalin is controlled under the Misuse of Drugs Act 1971 as a class C substance and scheduled under the Misuse of Drugs Regulations 2001 as schedule 3 (as of 1 April 2019). A footnote has been added by NICE to this guideline to reflect this change. Minor updates since publication July 2019: Recommendation 1.4.39 was amended to remove structured problem solving as a care and management option as this had originally been included in error. June 2018: Recommendation 1.2.13 was amended with advice on CBT. Recommendation 1.2.26 was updated with a link to the newest evidence on use of antipsychotics for treatment of GAD. Recommendation 1.4.7 was added to link to existing guidance on identifying treatment options for common mental health problems. Recommendation 1.4.10 on low-intensity interventions for mild to moderate panic disorder and 1.4.13 on treatment for moderate to severe panic disorder were added from the NICE guideline on common mental health disorders. Section 1.4 on stepped care for people with panic disorder was reordered.</strong></p></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/Book"><div class="meta-content fm-sec"><div class="iconblock whole_rhythm clearfix no_top_margin"><a href="http://www.bps.org.uk/" title="British Psychological Society" class="img_link icnblk_img" ref="pagearea=logo&targetsite=external&targetcat=link&targettype=publisher"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nicecg113-lrg.png" alt="Cover of Generalised Anxiety Disorder in Adults" /></a><div class="icnblk_cntnt"><h1 id="_NBK83459_"><span itemprop="name">Generalised Anxiety Disorder in Adults</span></h1><div class="subtitle">Management in Primary, Secondary and Community Care</div><p><i>NICE Clinical Guidelines, No. 113</i></p><p class="contrib-group"><h4>Authors</h4><span itemprop="author">National Collaborating Centre for Mental Health (UK)</span>.</p><div class="half_rhythm">Leicester (UK): <a href="http://www.bps.org.uk/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=publisher"><span itemprop="publisher">British Psychological Society</span></a>; <span itemprop="datePublished">2011</span>.<div class="small">ISBN-13: <span itemprop="isbn">978-1-904671-42-8</span></div></div><div><a href="/books/about/copyright/">Copyright</a> © 2011, The British Psychological Society & The Royal College of Psychiatrists.</div></div></div></div><div class="body-content whole_rhythm" itemprop="text"><div itemprop="description"><p>This clinical guideline is an update of NICE’s previous guidance on generalised anxiety disorder. It was commissioned by NICE and developed by the National Collaborating Centre for Mental Health, and sets out clear evidence- and consensus-based recommendations for healthcare professionals on how to treat and manage generalised anxiety disorder in adults.</p><p>Around 4.4% of adults in England are affected by generalised anxiety disorder. It can become chronic if it is not treated, often co-occurs with other anxiety and depressive disorders and is associated with substantial disability. This guideline is an indispensable tool in enabling healthcare professionals to identify generalised anxiety disorder and provide the most effective treatments in a stepped-care framework.</p><p>This new guideline, which updates all the reviews of the previous guideline, presents and appraises the evidence for low- and high-intensity psychological interventions, drug treatment and other physical interventions, and also provides insight into the experience of care of people with generalised anxiety disorder. An important feature of the new guideline is the economic modelling that was undertaken in the areas of drug treatments and computerised cognitive behavioural therapy.</p><p>The guideline also partially updates the NICE Technology Appraisal 97, <i>Computerised Cognitive Behaviour Therapy for Depression and Anxiety</i>. This update focuses on CCBT for panic disorder only.</p></div><div><h2>Contents</h2><ul id="toc_tllNBK83459_toc_nicecg113_fm_s1" class="simple-list toc toc-toggle"><li class="half_rhythm" id="toc_itm_NBK83459_toc_nicecg113_fm_s1"><a class="toc-item" href="/books/n/nicecg113/nicecg113.fm.s1/">GUIDELINE DEVELOPMENT GROUP MEMBERS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch1"><a class="toc-item" href="/books/n/nicecg113/ch1/">1. PREFACE</a><ul id="toc_lst_NBK83459_toc_ch1" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch1_s1"><a class="toc-item" href="/books/n/nicecg113/ch1/#ch1.s1">1.1. NATIONAL GUIDELINES</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch1_s8"><a class="toc-item" href="/books/n/nicecg113/ch1/#ch1.s8">1.2. THE NATIONAL GENERALISED ANXIETY DISORDER GUIDELINE</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch2"><a class="toc-item" href="/books/n/nicecg113/ch2/">2. GENERALISED ANXIETY DISORDER</a><ul id="toc_lst_NBK83459_toc_ch2" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch2_s1"><a class="toc-item" href="/books/n/nicecg113/ch2/#ch2.s1">2.1. INTRODUCTION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch2_s2"><a class="toc-item" href="/books/n/nicecg113/ch2/#ch2.s2">2.2. THE DISORDER</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch2_s8"><a class="toc-item" href="/books/n/nicecg113/ch2/#ch2.s8">2.3. AETIOLOGY</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch2_s9"><a class="toc-item" href="/books/n/nicecg113/ch2/#ch2.s9">2.4. TREATMENT AND MANAGEMENT IN THE NHS</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3"><a class="toc-item" href="/books/n/nicecg113/ch3/">3. METHODS USED TO DEVELOP THIS GUIDELINE</a><ul id="toc_lst_NBK83459_toc_ch3" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s1"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s1">3.1. OVERVIEW</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s2"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s2">3.2. THE SCOPE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s3"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s3">3.3. THE GUIDELINE DEVELOPMENT GROUP</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s8"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s8">3.4. REVIEW QUESTIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s9"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s9">3.5. SYSTEMATIC CLINICAL LITERATURE REVIEW</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s30"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s30">3.6. HEALTH ECONOMICS METHODS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s42"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s42">3.7. STAKEHOLDER CONTRIBUTIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch3_s43"><a class="toc-item" href="/books/n/nicecg113/ch3/#ch3.s43">3.8. VALIDATION OF THE GUIDELINE</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch4"><a class="toc-item" href="/books/n/nicecg113/ch4/">4. EXPERIENCE OF CARE</a><ul id="toc_lst_NBK83459_toc_ch4" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch4_s1"><a class="toc-item" href="/books/n/nicecg113/ch4/#ch4.s1">4.1. INTRODUCTION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch4_s2"><a class="toc-item" href="/books/n/nicecg113/ch4/#ch4.s2">4.2. PERSONAL ACCOUNTS – PEOPLE WITH GENERALISED ANXIETY DISORDER</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch4_s10"><a class="toc-item" href="/books/n/nicecg113/ch4/#ch4.s10">4.3. PERSONAL ACCOUNTS – CARERS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch4_s14"><a class="toc-item" href="/books/n/nicecg113/ch4/#ch4.s14">4.4. REVIEW OF THE LITERATURE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch4_s27"><a class="toc-item" href="/books/n/nicecg113/ch4/#ch4.s27">4.5. FROM EVIDENCE TO RECOMMENDATIONS</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch5"><a class="toc-item" href="/books/n/nicecg113/ch5/">5. ASSESSMENT AND SERVICE DELIVERY</a><ul id="toc_lst_NBK83459_toc_ch5" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch5_s1"><a class="toc-item" href="/books/n/nicecg113/ch5/#ch5.s1">5.1. INTRODUCTION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch5_s2"><a class="toc-item" href="/books/n/nicecg113/ch5/#ch5.s2">5.2. RECOGNITION AND ASSESSMENT</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch5_s5"><a class="toc-item" href="/books/n/nicecg113/ch5/#ch5.s5">5.3. FROM EVIDENCE TO RECOMMENDATIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch5_s8"><a class="toc-item" href="/books/n/nicecg113/ch5/#ch5.s8">5.4. STEPPED CARE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch5_s21"><a class="toc-item" href="/books/n/nicecg113/ch5/#ch5.s21">5.5. COLLABORATIVE CARE</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6"><a class="toc-item" href="/books/n/nicecg113/ch6/">6. LOW-INTENSITY PSYCHOLOGICAL INTERVENTIONS</a><ul id="toc_lst_NBK83459_toc_ch6" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6_s1"><a class="toc-item" href="/books/n/nicecg113/ch6/#ch6.s1">6.1. INTRODUCTION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6_s9"><a class="toc-item" href="/books/n/nicecg113/ch6/#ch6.s9">6.2. NON-FACILITATED SELF-HELP</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6_s14"><a class="toc-item" href="/books/n/nicecg113/ch6/#ch6.s14">6.3. GUIDED SELF-HELP</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6_s19"><a class="toc-item" href="/books/n/nicecg113/ch6/#ch6.s19">6.4. PSYCHOEDUCATIONAL GROUPS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6_s24"><a class="toc-item" href="/books/n/nicecg113/ch6/#ch6.s24">6.5. MODES OF DELIVERY</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6_s31"><a class="toc-item" href="/books/n/nicecg113/ch6/#ch6.s31">6.6. HEALTH ECONOMIC EVIDENCE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch6_s45"><a class="toc-item" href="/books/n/nicecg113/ch6/#ch6.s45">6.7. FROM EVIDENCE TO RECOMMENDATIONS</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7"><a class="toc-item" href="/books/n/nicecg113/ch7/">7. HIGH-INTENSITY PSYCHOLOGICAL INTERVENTIONS</a><ul id="toc_lst_NBK83459_toc_ch7" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s1"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s1">7.1. INTRODUCTION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s8"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s8">7.2. REVIEW OF HIGH-INTENSITY INTERVENTIONS FOR GENERALISED ANXIETY DISORDER</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s12"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s12">7.3. COGNITIVE BEHAVIOURAL THERAPY</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s38"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s38">7.4. APPLIED RELAXATION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s44"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s44">7.5. PSYCHODYNAMIC THERAPY</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s50"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s50">7.6. OTHER INTERVENTIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s56"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s56">7.7. COMBINED TREATMENTS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s62"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s62">7.8. MODE OF DELIVERY</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s69"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s69">7.9. OVERALL CLINICAL SUMMARY</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s74"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s74">7.10. HEALTH ECONOMIC EVIDENCE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch7_s78"><a class="toc-item" href="/books/n/nicecg113/ch7/#ch7.s78">7.11. FROM EVIDENCE TO RECOMMENDATIONS</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8"><a class="toc-item" href="/books/n/nicecg113/ch8/">8. PHARMACOLOGICAL AND PHYSICAL INTERVENTIONS</a><ul id="toc_lst_NBK83459_toc_ch8" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s1"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s1">8.1. INTRODUCTION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s4"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s4">8.2. PHARMACOLOGICAL INTERVENTIONS COMPARED WITH PLACEBO</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s32"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s32">8.3. HEAD-TO-HEAD TRIALS OF PHARMACOLOGICAL INTERVENTIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s45"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s45">8.4. EFFECTS OF DOSE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s63"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s63">8.5. MAINTENANCE TREATMENT</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s68"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s68">8.6. MANAGEMENT OF NON-RESPONSE TO PHARMACOLOGICAL INTERVENTIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s77"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s77">8.7. SIDE EFFECTS OF PHARMACOLOGICAL INTERVENTIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s93"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s93">8.8. HEALTH ECONOMIC EVIDENCE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s112"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s112">8.9. FROM EVIDENCE TO RECOMMENDATIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s117"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s117">8.10. RECOMMENDATIONS</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch8_s123"><a class="toc-item" href="/books/n/nicecg113/ch8/#ch8.s123">8.11. OTHER INTERVENTIONS</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch9"><a class="toc-item" href="/books/n/nicecg113/ch9/">9. COMPUTERISED COGNITIVE BEHAVIOURAL THERAPY FOR PANIC DISORDER</a><ul id="toc_lst_NBK83459_toc_ch9" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch9_s1"><a class="toc-item" href="/books/n/nicecg113/ch9/#ch9.s1">9.1. INTRODUCTION</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch9_s4"><a class="toc-item" href="/books/n/nicecg113/ch9/#ch9.s4">9.2. CLINICAL EVIDENCE FOR COMPUTERISED COGNITIVE BEHAVIOURAL THERAPY FOR PANIC DISORDER</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch9_s19"><a class="toc-item" href="/books/n/nicecg113/ch9/#ch9.s19">9.3. HEALTH ECONOMIC EVIDENCE</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch9_s35"><a class="toc-item" href="/books/n/nicecg113/ch9/#ch9.s35">9.4. FROM EVIDENCE TO RECOMMENDATIONS</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch10"><a class="toc-item" href="/books/n/nicecg113/ch10/">10. SUMMARY OF RECOMMENDATIONS</a><ul id="toc_lst_NBK83459_toc_ch10" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch10_s1"><a class="toc-item" href="/books/n/nicecg113/ch10/#ch10.s1">10.1. PRINCIPLES OF CARE FOR PEOPLE WITH GENERALISED ANXIETY DISORDER (GAD)</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_ch10_s3"><a class="toc-item" href="/books/n/nicecg113/ch10/#ch10.s3">10.2. STEPPED CARE FOR PEOPLE WITH GENERALISED ANXIETY DISORDER</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_appgroup1"><a class="toc-item" href="/books/n/nicecg113/appendixes.appgroup1/">APPENDICES</a><ul id="toc_lst_NBK83459_toc_appendixes_appgroup1" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app1"><a class="toc-item" href="/books/n/nicecg113/appendixes.app1/">Appendix 1. Scope for the development of the clinical guideline</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app2"><a class="toc-item" href="/books/n/nicecg113/appendixes.app2/">Appendix 2. Scope for the original anxiety guideline</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app3"><a class="toc-item" href="/books/n/nicecg113/appendixes.app3/">Appendix 3. Declarations of interests by guideline development group members</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app4"><a class="toc-item" href="/books/n/nicecg113/appendixes.app4/">Appendix 4. Stakeholders and experts who submitted comments in response to the consultation draft of the guideline</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app5"><a class="toc-item" href="/books/n/nicecg113/appendixes.app5/">Appendix 5. Researchers contacted to request information about unpublished or soon-to-be published studies</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app6"><a class="toc-item" href="/books/n/nicecg113/appendixes.app6/">Appendix 6. Review questions</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app7"><a class="toc-item" href="/books/n/nicecg113/appendixes.app7/">Appendix 7. Review protocols</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app8"><a class="toc-item" href="/books/n/nicecg113/appendixes.app8/">Appendix 8. Search strategies for the identification of clinical studies</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app9"><a class="toc-item" href="/books/n/nicecg113/appendixes.app9/">Appendix 9. Clinical study data extraction form</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app10"><a class="toc-item" href="/books/n/nicecg113/appendixes.app10/">Appendix 10. Quality checklists for clinical studies and reviews</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app11"><a class="toc-item" href="/books/n/nicecg113/appendixes.app11/">Appendix 11. Search strategies for the identification of health economic evidence</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app12"><a class="toc-item" href="/books/n/nicecg113/appendixes.app12/">Appendix 12. Methodology checklist for economic studies</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app13"><a class="toc-item" href="/books/n/nicecg113/appendixes.app13/">Appendix 13. Network (mixed treatment comparison) meta-analytic methods used in the economic analysis of pharmacological treatments for people with GAD</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app14"><a class="toc-item" href="/books/n/nicecg113/appendixes.app14/">Appendix 14. Economic Plan</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app15"><a class="toc-item" href="/books/n/nicecg113/appendixes.app15/">Appendix 15. Clinical study characteristics tables</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app16"><a class="toc-item" href="/books/n/nicecg113/appendixes.app16/">Appendix 16. Clinical evidence forest plots</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app17"><a class="toc-item" href="/books/n/nicecg113/appendixes.app17/">Appendix 17. Completed methodology checklists for economic studies</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_appendixes_app18"><a class="toc-item" href="/books/n/nicecg113/appendixes.app18/">Appendix 18. GRADE evidence profiles</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_references_rl1"><a class="toc-item" href="/books/n/nicecg113/references.rl1/">REFERENCES</a></li><li class="half_rhythm" id="toc_itm_NBK83459_toc_nicecg113_abbreviations_s1"><a class="toc-item" href="/books/n/nicecg113/nicecg113.abbreviations.s1/">ABBREVIATIONS</a></li></ul></div><div><p>The views presented in this book do not necessarily reflect those of the British Psychological Society, and the publishers are not responsible for any error of omission or fact. The British Psychological Society is a registered charity (no. 229642).</p></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 2011, The British Psychological Society & The Royal College of Psychiatrists.<p class="small">All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.</p></div><div class="small"><span class="label">Bookshelf ID: NBK83459</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/22536620" title="PubMed record of this title" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">22536620</a></span></div><div style="margin-top:2em" class="bk_noprnt"><div class="pagination bk_noprnt"><span class="inactive page_link prev">< Prev</span><a class="active page_link next" href="/books/n/nicecg113/nicecg113.fm.s1/" title="Next page in this title">Next ></a></div></div></div></div>
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-toc&ncbi_acc=NBK83459&ncbi_domain=nicecg113&ncbi_report=printable&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK83459/?report=printable&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |